tiprankstipranks
Trending News
More News >
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
UK Market
Advertisement

Dr. Martens Plc (DOCS) Earnings Dates, Call Summary & Reports

Compare
152 Followers

Earnings Data

Report Date
May 28, 2026
Before Open (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
0.05
Last Year’s EPS
0.04
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 20, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. There was notable improvement in revenue quality, operating profit, and debt reduction. Growth was observed in the Americas and APAC regions, along with an increase in full-price sales. However, challenges in the EMEA market, particularly in direct-to-consumer revenue, and ongoing issues with boots and sandals, along with tariff headwinds, were highlighted as areas of concern.
Company Guidance
During the call, the company provided guidance indicating strong performance in key metrics and adherence to their strategic plan. They reported a year-on-year revenue increase of GBP 2.7 million, reaching GBP 327.3 million, with a focus on improving revenue quality through full-price sales. Operating profit improved by GBP 6.5 million, shifting from a loss last year to a GBP 3.4 million profit. However, the profit before tax remains a loss, albeit significantly improved from the previous year. The company's dividend was declared at 0.85p, and net bank debt decreased by GBP 33 million to GBP 154 million. The strategy included focusing on reducing markdowns, expanding product offerings, and leveraging partnerships in new markets. The company also emphasized cost control, with a net debt-to-EBITDA ratio finishing at 2.1x, and aimed for sustainable growth in FY '27 and beyond.
Revenue Growth and Quality Improvement
Revenue increased by GBP 2.7 million to GBP 327.3 million year-on-year, with a focus on full price sales and a reduction in markdown sales, resulting in better revenue quality.
Operating Profit Improvement
Operating profit improved by GBP 6.5 million, swinging from a loss last year to a GBP 3.4 million profit this year, despite some headwinds.
Significant Debt Reduction
Net bank debt reduced by GBP 33 million year-on-year to GBP 154 million, showing strong balance sheet management.
Growth in the Americas and APAC
The Americas returned to growth with a GBP 4.8 million increase in DTC, and APAC saw continued year-on-year growth, especially in South Korea retail.
Full-Price Sales Increase
DTC full-price revenue is up 6% year-on-year, with a 10% increase in new consumers buying at full price.

Dr. Martens Plc (GB:DOCS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GB:DOCS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 28, 2026
2026 (Q4)
0.05 / -
0.036
Nov 20, 2025
2026 (Q2)
-0.01 / >-0.01
-0.01330.77% (<+0.01)
Jun 05, 2025
2025 (Q4)
0.03 / 0.04
0.051-29.41% (-0.01)
Nov 28, 2024
2025 (Q2)
-0.02 / -0.01
0.019-168.42% (-0.03)
May 30, 2024
2024 (Q4)
0.05 / 0.05
0.084-39.29% (-0.03)
Nov 30, 2023
2024 (Q2)
0.02 / 0.02
0.045-57.78% (-0.03)
Jun 01, 2023
2023 (Q4)
0.10 / 0.08
0.132-36.36% (-0.05)
Nov 24, 2022
2023 (Q2)
0.05 / 0.04
0.048-6.25% (>-0.01)
Jun 01, 2022
2022 (Q4)
0.10 / 0.13
0.08260.98% (+0.05)
Dec 09, 2021
2022 (Q2)
0.03 / 0.05
0.084-42.86% (-0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:DOCS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 20, 2025
81.60p73.80p-9.56%
Jun 05, 2025
58.85p74.02p+25.78%
Nov 28, 2024
55.98p63.58p+13.58%
May 30, 2024
80.16p80.25p+0.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Dr. Martens Plc (GB:DOCS) report earnings?
Dr. Martens Plc (GB:DOCS) is schdueled to report earning on May 28, 2026, Before Open (Confirmed).
    What is Dr. Martens Plc (GB:DOCS) earnings time?
    Dr. Martens Plc (GB:DOCS) earnings time is at May 28, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Dr. Martens Plc stock?
          The P/E ratio of Dr. Martens Plc is N/A.
            What is GB:DOCS EPS forecast?
            GB:DOCS EPS forecast for the fiscal quarter 2026 (Q4) is 0.05.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis